Paul Volberding, MD

Professor
Epidemiology & Biostatistics
+1 415 476-5470

Dr. Volberding is a professor of medicine at UCSF. He is the co-director of the UCSF-Gladstone Center for AIDS Research, an NIH-funded program that supports a large variety of HIV related research across the entire University. As an oncologist, Dr. Volberding has a career-long interest in HIV-associated cancers including those common in resource limited settings. CFAR provides scientific core, mentoring and pilot research grants and work in international sites, especially in East Africa is central to the CFAR mission. Dr. Volberding is also an active supporter of the Infectious Diseases Institute in Kampala, Uganda which is a large and growing part of Makerere University. The IDI provides research training to promising young Ugandan scientists including those engaged in cancer-related research.

Publications: 

Frequency of Post Treatment Control Varies by ART Restart and Viral Load Criteria.

AIDS (London, England)

Fajnzylber J, Sharaf R, Hutchinson JN, Aga E, Bosch RJ, Hartogensis W, Jacobson JM, Connick E, Volberding P, Skiest DJ, Margolis D, Sneller MC, Little SJ, Gulick RM, Mellors JW, Gandhi RT, Schooley RT, Henry K, Tebas P, Deeks S, Chun TW, Collier AC, Hecht FM, Li JZ, CHAMP study team

The relationship of smoking and unhealthy alcohol use to the HIV care continuum among people with HIV in an integrated health care system.

Drug and alcohol dependence

Satre DD, Levine-Hall T, Sterling SA, Young-Wolff KC, Lam JO, Alexeeff S, Hojilla JC, Williams A, Justice AC, Sterne J, Cavassini M, Bryant KJ, Williams EC, Horberg MA, Volberding P, Weisner C, Silverberg MJ

Change in Condom Use in Populations Newly Aware of HIV Diagnosis in the United States and Canada: A Systematic Review and Meta-Analysis.

AIDS and behavior

Malekinejad M, Blodgett J, Horvath H, Parriott A, Hutchinson AB, Shrestha RK, McCabe D, Volberding P, Kahn JG

Health care utilization and HIV clinical outcomes among newly enrolled patients following Affordable Care Act implementation in a California integrated health system: a longitudinal study.

BMC health services research

Satre DD, Parthasarathy S, Silverberg MJ, Horberg M, Young-Wolff KC, Williams EC, Volberding P, Campbell CI

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel.

JAMA

Saag MS, Gandhi RT, Hoy JF, Landovitz RJ, Thompson MA, Sax PE, Smith DM, Benson CA, Buchbinder SP, Del Rio C, Eron JJ, Fätkenheuer G, Günthard HF, Molina JM, Jacobsen DM, Volberding PA

Sharing Experiences and Lessons: Medical Issues in Confronting the HIV Epidemic and COVID-19.

International journal of radiation oncology, biology, physics

Volberding P

Antiretroviral drug class and anaemia risk in the current treatment era among people living with HIV in the USA: a clinical cohort study.

BMJ open

Harding BN, Whitney BM, Nance RM, Crane HM, Burkholder G, Moore RD, Mathews WC, Eron JJ, Hunt PW, Volberding P, Rodriguez B, Mayer K, Saag MS, Kitahata MM, Heckbert SR, Delaney JAC

National Academies Consensus Report on Functional Assessment for Adults With Disabilities.

Archives of physical medicine and rehabilitation

Heinemann AW, Volberding PA

Implementing electronic substance use disorder and depression and anxiety screening and behavioral interventions in primary care clinics serving people with HIV: Protocol for the promoting access to care engagement (PACE) trial.

Contemporary clinical trials

Satre DD, Anderson AN, Leibowitz AS, Levine-Hall T, Slome S, Flamm J, Hare CB, McNeely J, Weisner CM, Horberg M, Volberding P, Silverberg MJ

Interventions to Reduce Unhealthy Alcohol Use among Primary Care Patients with HIV: the Health and Motivation Randomized Clinical Trial.

Journal of general internal medicine

Satre DD, Leibowitz AS, Leyden W, Catz SL, Hare CB, Jang H, Lam JO, Bryant KJ, Weisner CM, Sterling SA, Horberg M, Volberding P, Silverberg MJ

Cost-effectiveness of Hepatitis B Virus Infection Screening and Treatment or Vaccination in 6 High-risk Populations in the United States.

Open forum infectious diseases

Chahal HS, Peters MG, Harris AM, McCabe D, Volberding P, Kahn JG

The Control of HIV after Antiretroviral Medication Pause (CHAMP) study: post-treatment controllers identified from 14 clinical studies.

The Journal of infectious diseases

Namazi G, Fajnzylber JM, Aga E, Bosch R, Acosta EP, Sharaf R, Hartogensis W, Jacobson JM, Connick E, Volberding P, Skiest D, Margolis D, Sneller MC, Little SJ, Gianella S, Smith D, Kuritzkes DR, Gulick RM, Mellors JW, Mehraj V, Gandhi RT, Mitsuyasu R, Schooley RT, Henry K, Tebas P, Deeks S, Chun TW, Collier AC, Routy JP, Hecht FM, Walker BD, Li JZ

HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers.

The Journal of clinical investigation

Sharaf R, Lee GQ, Sun X, Etemad B, Aboukhater LM, Hu Z, Brumme ZL, Aga E, Bosch RJ, Wen Y, Namazi G, Gao C, Acosta EP, Gandhi RT, Jacobson JM, Skiest D, Margolis DM, Mitsuyasu R, Volberding P, Connick E, Kuritzkes DR, Lederman MM, Yu XG, Lichterfeld M, Li JZ

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel.

JAMA

Saag MS, Benson CA, Gandhi RT, Hoy JF, Landovitz RJ, Mugavero MJ, Sax PE, Smith DM, Thompson MA, Buchbinder SP, Del Rio C, Eron JJ, Fätkenheuer G, Günthard HF, Molina JM, Jacobsen DM, Volberding PA

EFFECT OF SHORT-TERM ART INTERRUPTION ON LEVELS OF INTEGRATED HIV DNA.

Journal of virology

Strongin Z, Sharaf R, VanBelzen DJ, Jacobson JM, Connick E, Volberding P, Skiest DJ, Gandhi RT, Kuritzkes DR, O'Doherty U, Li JZ

A Conversation Among the IAS-USA Board of Directors: Hot Topics and Emerging Data in HIV Research and Care.

Topics in antiviral medicine

Benson CA, Currier JS, Del Rio C, Gallant JE, Gulick RM, Marrazzo JM, Richman DD, Saag MS, Schooley RT, Volberding PA

Effectiveness of community-based condom distribution interventions to prevent HIV in the United States: A systematic review and meta-analysis.

PloS one

Malekinejad M, Parriott A, Blodgett JC, Horvath H, Shrestha RK, Hutchinson AB, Volberding P, Kahn JG

JAIDS: Transitions, Evolution, and Impact.

Journal of acquired immune deficiency syndromes (1999)

Volberding P, Blattner WA

Implementation and Operational Research: Affordable Care Act Implementation in a California Health Care System Leads to Growth in HIV-Positive Patient Enrollment and Changes in Patient Characteristics.

Journal of acquired immune deficiency syndromes (1999)

Satre DD, Altschuler A, Parthasarathy S, Silverberg MJ, Volberding P, Campbell CI

Long-term survival in AIDS-related primary central nervous system lymphoma.

Neuro-oncology

Gupta NK, Nolan A, Omuro A, Reid EG, Wang CC, Mannis G, Jaglal M, Chavez JC, Rubinstein PG, Griffin A, Abrams DI, Hwang J, Kaplan LD, Luce JA, Volberding P, Treseler PA, Rubenstein JL

Health impact of human rights testimony: harming the most vulnerable?

BMJ global health

Meffert SM, Shome S, Neylan TC, Musalo K, Fineberg HV, Cooke MM, Volberding PA, Goosby EP

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel.

JAMA

Günthard HF, Saag MS, Benson CA, del Rio C, Eron JJ, Gallant JE, Hoy JF, Mugavero MJ, Sax PE, Thompson MA, Gandhi RT, Landovitz RJ, Smith DM, Jacobsen DM, Volberding PA

Crowdsourcing HIV Test Promotion Videos: A Noninferiority Randomized Controlled Trial in China.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Tang W, Han L, Best J, Zhang Y, Mollan K, Kim J, Liu F, Hudgens M, Bayus B, Terris-Prestholt F, Galler S, Yang L, Peeling R, Volberding P, Ma B, Xu H, Yang B, Huang S, Fenton K, Wei C, Tucker JD

Building Networks for Global Clinical Research: The Basics.

Journal of orthopaedic trauma

Shearer DW, Volberding PA, Schemitsch EH, Cook GE, Slobogean GP, Morshed S

Exploring the social meaning of curing HIV: a qualitative study of people who inject drugs in Guangzhou, China.

AIDS research and human retroviruses

Chu CE, Wu F, He X, Ma Q, Cheng Y, Cai W, Volberding P, Tucker JD

Implementing Implementation Science: An Approach for HIV Prevention, Care and Treatment Programs.

Current HIV research

Lambdin BH, Cheng B, Peter T, Mbwambo J, Apollo T, Dunbar M, Udoh IC, Cattamanchi A, Geng EH, Volberding P

Words matter: Discussing research towards an HIV cure in research and clinical contexts.

Journal of acquired immune deficiency syndromes (1999)

Tucker JD, Volberding PA, Margolis DM, Rennie S, Barré-Sinoussi F

Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel.

JAMA

Günthard HF, Aberg JA, Eron JJ, Hoy JF, Telenti A, Benson CA, Burger DM, Cahn P, Gallant JE, Glesby MJ, Reiss P, Saag MS, Thomas DL, Jacobsen DM, Volberding PA

HIV cure: the target is clearer but not yet close.

Annals of internal medicine

Volberding P

Solving the mystery of JAIDS.

Journal of acquired immune deficiency syndromes (1999)

Volberding PA

Bringing the end in sight: consensus regarding HIV screening strategies.

Annals of internal medicine

Das M, Volberding P

A chronicle of hope and promise: the world as it was, as it is, and as it can be.

Journal of acquired immune deficiency syndromes (1999)

El-Sadr WM, Morrison JS, Quinn T, Volberding P

Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel.

JAMA

Thompson MA, Aberg JA, Hoy JF, Telenti A, Benson C, Cahn P, Eron JJ, Günthard HF, Hammer SM, Reiss P, Richman DD, Rizzardini G, Thomas DL, Jacobsen DM, Volberding PA

HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group.

Journal of acquired immune deficiency syndromes (1999)

High KP, Brennan-Ing M, Clifford DB, Cohen MH, Currier J, Deeks SG, Deren S, Effros RB, Gebo K, Goronzy JJ, Justice AC, Landay A, Levin J, Miotti PG, Munk RJ, Nass H, Rinaldo CR, Shlipak MG, Tracy R, Valcour V, Vance DE, Walston JD, Volberding P

Augmented HIV-specific interferon-gamma responses, but impaired lymphoproliferation during interruption of antiretroviral treatment initiated in primary HIV infection.

Journal of acquired immune deficiency syndromes (1999)

Connick E, Bosch RJ, Aga E, Schlichtemeier R, Demeter LM, Volberding P

Clinician attitudes about commercial support of continuing medical education: results of a detailed survey.

Archives of internal medicine

Tabas JA, Boscardin C, Jacobsen DM, Steinman MA, Volberding PA, Baron RB

HIV and premature aging: A field still in its infancy.

Annals of internal medicine

Martin J, Volberding P

Prevalence of primary resistance at baseline in acutely and recently infected subjects enrolled in AIDS clinical trials group protocol 371.

Journal of acquired immune deficiency syndromes (1999)

Dykes C, Mukherjee AL, Bosch RJ, Connick E, Volberding PA, Demeter LM

Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel.

JAMA

Thompson MA, Aberg JA, Cahn P, Montaner JS, Rizzardini G, Telenti A, Gatell JM, Günthard HF, Hammer SM, Hirsch MS, Jacobsen DM, Reiss P, Richman DD, Volberding PA, Yeni P, Schooley RT

Antiretroviral therapy and management of HIV infection.

Lancet (London, England)

Volberding PA, Deeks SG

Long-term clinical consequences of acute kidney injury in the HIV-infected.

Kidney international

Choi AI, Li Y, Parikh C, Volberding PA, Shlipak MG

Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons.

Circulation

Choi AI, Li Y, Deeks SG, Grunfeld C, Volberding PA, Shlipak MG

Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment.

AIDS (London, England)

Volberding P, Demeter L, Bosch RJ, Aga E, Pettinelli C, Hirsch M, Vogler M, Martinez A, Little S, Connick E

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

JAMA

Hammer SM, Eron JJ, Reiss P, Schooley RT, Thompson MA, Walmsley S, Cahn P, Fischl MA, Gatell JM, Hirsch MS, Jacobsen DM, Montaner JS, Richman DD, Yeni PG, Volberding PA

Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Choi AI, Rodriguez RA, Bacchetti P, Volberding PA, Havlir D, Bertenthal D, Bostrom A, O'Hare AM

Racial differences in end-stage renal disease rates in HIV infection versus diabetes.

Journal of the American Society of Nephrology : JASN

Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Volberding PA, O'Hare AM

Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Behler CM, Vittinghoff E, Lin F, Chung RT, Peters MG, Robbins GK, Volberding PA

Relationship between antiretroviral prescribing patterns and treatment guidelines in treatment-naive HIV-1-infected US veterans (1992-2004).

Journal of acquired immune deficiency syndromes (1999)

Holodniy M, Hornberger J, Rapoport D, Robertus K, MaCurdy TE, Lopez J, Volberding P, Deyton L

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.

JAMA

Hammer SM, Saag MS, Schechter M, Montaner JS, Schooley RT, Jacobsen DM, Thompson MA, Carpenter CC, Fischl MA, Gazzard BG, Gatell JM, Hirsch MS, Katzenstein DA, Richman DD, Vella S, Yeni PG, Volberding PA

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel.

Topics in HIV medicine : a publication of the International AIDS Society, USA

Hammer SM, Saag MS, Schechter M, Montaner JS, Schooley RT, Jacobsen DM, Thompson MA, Carpenter CC, Fischl MA, Gazzard BG, Gatell JM, Hirsch MS, Katzenstein DA, Richman DD, Vella S, Yeni PG, Volberding PA

The New York case: lessons being learned.

Annals of internal medicine

Volberding PA

Anemia and HIV in the antiretroviral era: potential significance of testosterone.

AIDS research and human retroviruses

Behler C, Shade S, Gregory K, Abrams D, Volberding P

Baboon bone-marrow xenotransplant in a patient with advanced HIV disease: case report and 8-year follow-up.

Transplantation

Michaels MG, Kaufman C, Volberding PA, Gupta P, Switzer WM, Heneine W, Sandstrom P, Kaplan L, Swift P, Damon L, Ildstad ST

Epoetin alfa for treatment of anemia in HIV-infected patients: past, present, and future.

Journal of acquired immune deficiency syndromes (1999)

Henry DH, Volberding PA, Leitz G

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.

The New England journal of medicine

Chung RT, Andersen J, Volberding P, Robbins GK, Liu T, Sherman KE, Peters MG, Koziel MJ, Bhan AK, Alston B, Colquhoun D, Nevin T, Harb G, van der Horst C

Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

JAMA

Yeni PG, Hammer SM, Hirsch MS, Saag MS, Schechter M, Carpenter CC, Fischl MA, Gatell JM, Gazzard BG, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Schooley RT, Thompson MA, Vella S, Volberding PA

Anemia in HIV infection: clinical impact and evidence-based management strategies.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Volberding PA, Levine AM, Dieterich D, Mildvan D, Mitsuyasu R, Saag M

Opportunities and options for treatment research in resource-constrained settings.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Volberding PA

HIV therapy in 2003: consensus and controversy.

AIDS (London, England)

Volberding PA

The pavia consensus statement.

AIDS (London, England)

Volberding PA, Murphy RL, Barbaro G, Barbarini G, Bruno R, Cirelli A, Currie PF, Di Lorenzo G, Fantoni M, Filiced G, Galli M, Grisorio B, Moroni M, Recusani F, Sacchi P, Scevola D, Stein JH, Torre D, Vittecoq D

A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy.

AIDS (London, England)

Lalezari JP, Eron JJ, Carlson M, Cohen C, DeJesus E, Arduino RC, Gallant JE, Volberding P, Murphy RL, Valentine F, Nelson EL, Sista PR, Dusek A, Kilby JM

Human immunodeficiency virus hematology.

Hematology. American Society of Hematology. Education Program

Volberding PA, Baker KR, Levine AM

What can modeling tell us about the threat of antiviral drug resistance?

Current opinion in infectious diseases

Blower S, Volberding P

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

JAMA

Yeni PG, Hammer SM, Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schechter M, Schooley RT, Thompson MA, Vella S, Volberding PA

The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults.

AIDS research and human retroviruses

Kilby JM, Lalezari JP, Eron JJ, Carlson M, Cohen C, Arduino RC, Goodgame JC, Gallant JE, Volberding P, Murphy RL, Valentine F, Saag MS, Nelson EL, Sista PR, Dusek A

Who cares for AIDS?

Journal of general internal medicine

Volberding PA